This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks)
Age >18 years
Provision of written informed consent
Willingness and ability to complete follow-up assessments for 12 months
Surgical treatment of the affected tendon within the previous 6 months
Corticosteroid injection within the last month
Systemic inflammatory disease (e.g., rheumatoid arthritis)
Coagulopathies or ongoing anticoagulant therapy
ReSport Clinic
Lead sponsor
BioSmartData
Collaborator